Masterminds Behind Pharmaceutical Fraud Deserve Prison Time
By: Joseph E. B. “Jeb” White 9/2010
News & Views
Our Blog
U.S. Justice Department Takes Tough Stance on MA Medicare Fraud in the Cases Against Kaiser Permanente
DOJ recently joined forces with numerous private plaintiffs against healthcare giant Kaiser Permanente. The original whistleblower lawsuit, filed under the qui tam provisions of the False Claims…
The Inspector General’s Strategic Plan for 2020-2025
In addition to fighting fraud, HHS-OIG performs a myriad of other functions that are worth mentioning. In its Strategic Plan for 2025, it articulated a…
OIG Is the Fulcrum in the Fight Against HSS Program Fraud
The U.S. Department of Health and Human Services (HSS) provides over $1 trillion in health and human services to the American people. Every day, more…
Paying Physicians to Draw Blood and Process Samples Can Be an Illegal Kickback – U.S. V. Mallory
In U.S. v. Mallory, the 4th Circuit Court of Appeals issued a recent opinion regarding violations of the Federal Anti-Kickback Statute and involving Medicare Fraud. …
What Does “Materiality” and “Scienter” Have to Do With the False Claims Act?
A Falsehood Must be Material to be Actionable If a falsehood did not have any impact on whether the government decided to pay a benefit,…
Healthcare Fraud Risk Framework
Healthcare Fraud can take multiple forms. The quintessential Healthcare Fraud schemes include fraudulent billing for services not provided, billing for services provided but were not…
FDA APPROVES FIRST DRUG TO TREAT ALZHEIMER’S IN 17 YEARS
On June 7th, 2021, the FDA approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s disease, the first drug approved to treat Alzheimer’s in 17…
What is the Daubert Standard as it Relates to Expert Testimony?
Why Do We Sometimes Need Expert Witnesses to Resolve Legal Disputes? The standard legal reason that judges typically give to juries as to why an…
What Makes Something a “False” Certification Under the False Claims Act?
United States ex rel. Montcrieff v. Peripheral Vascular Associates – Part III We have all heard the term “false.” It is something that is ‘not…
Published Articles
Nolan Auerbach lawyers serve as respected leaders and expert sources for Medicare fraud and other healthcare qui tam lawsuits. Published articles written by our attorneys include:
The Future of the False Claims Act: FERA and Beyond
By: Joseph E. B. “Jeb” White 6/2010
Enforcement of Current Good Manufacturing Practices, Chapter 1.2
By: Kenneth J. Nolan 3/2008
cGMP Violations may be the Basis for Qui Tam Lawsuits in the United States
By: Kenneth J. Nolan, 8/2004
Blowing the Whistle on Healthcare Fraud Healthcare Purchasing News
By: Kenneth J. Nolan, 7/2004
Off Label Marketing: The New Reality
By: Kenneth J. Nolan, 3/2004
Litigation Threatens Off-Label Pharmaceutical Sales
By: Kenneth J. Nolan, 1/21/2004
Pharmaceutical Companies Liable for Fraudulent Research by Subcontractors
By: Kenneth J. Nolan, 2004
Reality Check For All Pharmaceutical Companies: Compliance Oversight Must Now Include Research Subcontractors
By: Kenneth J. Nolan, 10/2003
End Game for Pharmaceutical Kickbacks
By: Kenneth J. Nolan, 9/3/2003
RX for Industry Fraud
By: Kenneth J. Nolan, 5/2002
10 Common Obstacles Facing Whistleblowers Pursuing False Claims Lawsuits Against Health Care Organizations
By: Kenneth J. Nolan, 7/12/2001
Standing to Sue Under the Federal False Claims Act (The Supreme Court Declines to Take the Whistle Away from Whistleblowers)
By: Kenneth J. Nolan and Michael Flynn, 8/2000
What Physicians, Hospital Administrators, Billing Personnel Need to Know About the False Claims Act
By: Kenneth J. Nolan, 9/1998
Our Firm In the News
$168 Million Payout to Johnson & Johnson Whistleblowers
CNN MoneyThe $2.2 billion settlement between Johnson & Johnson and authorities means a record payout for whistleblowers. Joe Strom, a former employee of Johnson & Johnson subsidiary, Scios, will receive the entire $28 million awarded in California. He first brought suit against J&J in 2005 and ultimately helped government…
Nurse Pleads Guilty to Taking Kickbacks From Drug Maker
The New York TimesA Connecticut nurse has pleaded guilty to federal charges of accepting $83,000 in kickbacks from Insys Therapeutics, an Arizona drug manufacturer that sells the powerful painkiller Subsys. According to federal prosecutors, the nurse worked in a pain clinic and was a top prescriber of Sybsys to Medicare patients…
High Court Ruling on FCA Limitations Period, Bar on Filings Gives Providers Mixed Result
Bloomberg BNAOn May 26, 2015 a unanimous decision was announced by the U.S. Supreme Court that said a strict six-year limitations period applies to civil actions brought by whistle-blowers under the False Claims Act.
What Happened After She Helped Nurse at Catholic Healthcare Blow Whistle on her Employer?
Law.comA settlement agreement between Dignity Health and the Justice Deparment was announced on October 30, 2014 for $36.7 million. The whistleblower in this case, Kathleen Hawkins, a registered nurse who worked as a director of medical management at Catholic Healthcare
Jeb White & Jim Helmer Show How to Dismantle Common False Claims Act Defenses During National Webcast
ReutersNolan Auerbach & White Partner, Joseph E.B. “Jeb” White presented to an audience of over 500 attendees during a BNA Bloomberg webcast titled, “Common Defenses to False Claims Act and How to Defeat Them.”
Jeb White Appears on NPR Affiliate Radio Show
MarketWatchRecently Nolan Auerbach & White Partner, Jeb White, appeared on an hour-long radio show for National Public Radio (NPR) affiliate in Harrisburg, Pennsylvania. The “Smart Talk” radio program focused on whistleblower laws and Mr. White was joined on the program by Penn State Law Professor Katherine Pearson.
OUR PROMISE When it feels like you are facing insurmountable odds, we will be there for you!
We know the struggles whistleblowers face before contacting us, and know that deciding to be a whistleblower can be difficult. We will be with you every step of the way, strong and proud, helping you stand up for what is right.